Sub-millimetre accuracy of 3D measurements and texture analysis of Diabetic Foot Ulcers

糖尿病足溃疡的 3D 测量和纹理分析的亚毫米精度

• 批准号: 10060874
• 金额: $ 1.25万
• 依托单位: MEDICAL INTELLIGENCE GROUP LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10060874
• 关键词: Sub; millimetre; accuracy; 3D; measurements

Diabetes is the 9th leading cause of death globally and a leading co-morbidity to cardiac related deaths. The UK has over 4M diabetics who are 23x more likely to develop diabetic foot ulcers (DFUs). 10% of these DFUs will lead to foot amputation and a mortality rate of 50% within two years. Globally the International Diabetes Federation estimates a prevalence of over 450 million diabetics, projected to grow to 578 million by 2030\.Medical Intelligence Group (MIG) offers a 3 pillar innovative solution to this; remote at home monitoring technology used by patients themselves, early ulcer detection system and AI predictive modelling. The key impacts are improvements to patient outcomes through increased ulcer monitoring for timely treatments, relieving stress and cost saving for the NHS. Through catching deteriorating ulcers earlier on in the patient journey, reduces the need for amputations avoiding surgery and aftercare costs. More importantly avoiding amputations for patients ensures quality of life for the patient both socially and economically as those with amputations have a 50% mortality rate within just 2 years.

糖尿病是全球第九大死因，也是心脏相关死亡的主要共病。英国有超过400万糖尿病患者，他们患糖尿病足溃疡（DFU）的可能性高出23倍。这些DFU中的10%将导致足部截肢，两年内的死亡率为50%。据国际糖尿病联合会估计，全球糖尿病患病率超过4.5亿，预计到2030年将增长到5.78亿。Medical Intelligence Group（IMG）为此提供了三大支柱创新解决方案：患者自己使用的远程家庭监测技术，早期溃疡检测系统和人工智能预测建模。主要影响是通过增加溃疡监测以及时治疗、缓解压力和为NHS节省成本来改善患者结局。通过在患者旅程的早期发现恶化的溃疡，减少了截肢的需要，避免了手术和术后护理费用。更重要的是，避免截肢可以确保患者的社会和经济生活质量，因为截肢患者在短短2年内的死亡率为50%。